Cytex receives 4 new federal grants

Cytex is pleased to announce the receipt of four new research awards from the National Institutes of Health.  Two awards are part of the recent Commercialization Readiness Pilot initiative offered by NIH, and will assist Cytex in its commercialization efforts of its hip implant.  The other two awards are part of NIH’s SBIR (Small Business Innovation Research) program, and will allow Cytex to launch projects exploring inflammatory modeling and genetically responsive tissue engineering.  Cytex is grateful for the support of the National Institutes of Health!